Nurr1 blocks the mitogenic effect of FGF-2 and EGF, inducing olfactory bulb neural stem cells to adopt dopaminergic and dopaminergic-GABAergic neuronal phenotypes.
Vergaño-Vera E, Díaz-Guerra E, Rodríguez-Traver E, Méndez-Gómez HR, Solís Ó, Pignatelli J, Pickel J, Lee SH, Moratalla R, Vicario-Abejón C
Nurr1 forces olfactory bulb stem cells to stop dividing and mature into dopamine-releasing neurons in mouse models. This process involves blocking growth signals and upregulating specific genes required for dopamine production and release.
- Nurr1 stops stem cell division and triggers maturation into dopamine neurons.
- Induced neurons release dopamine and respond to dopamine receptor stimulation.
- Some cells become dual-function neurons releasing both dopamine and GABA.
- Adding Neurogenin2 alongside Nurr1 reduces the number of dopamine neurons formed.
Molecular interactions of FGF23 and PTH in phosphate regulation.
Lanske B, Razzaque MS
This study finds that parathyroid hormone (PTH) activates the Nurr1 protein in bone cells, which turns on the gene that makes FGF23, a key hormone for controlling phosphate levels in the blood.
- PTH triggers FGF23 production in bone via Nurr1 activation
- Nurr1 is a nuclear receptor that directly controls FGF23 gene expression
- This pathway links calcium and phosphate regulation through hormone signaling
- Disruptions may cause phosphate imbalances seen in kidney and bone disorders
Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression.
Le Grand JN, Gonzalez-Cano L, Pavlou MA, Schwamborn JC
This review argues that Parkinson's disease involves defects in neural stem cell development and adult neurogenesis, linking genetic mutations to both the onset and progression of symptoms. It highlights how PD-related genes regulate the generation and maintenance of dopamine neurons during embryonic and adult stages.
- Parkinson's disease may be a developmental disorder involving neurogenesis defects.
- Non-motor symptoms often precede motor signs by over a decade.
- PD genes like SNCA and LRRK2 affect adult neurogenesis and dopamine neuron maintenance.
- Animal models show deregulated embryonic neurogenesis linked to PD-related gene deficiencies.
Differences in prefrontal cortex GABA/glutamate ratio after acute restraint stress in rats are associated with specific behavioral and neurobiological patterns.
Drouet JB, Fauvelle F, Maunoir-Regimbal S, Fidier N, Maury R, Peinnequin A, Denis J, Buguet A, Canini F
This rat study links individual differences in stress response to changes in brain chemistry and gene activity, specifically noting that Nr4a2 expression decreases during high-stress responses. The findings describe basic neurobiological mechanisms of stress in animals and do not provide clinical insights or treatment options for NR4A2-related syndromes.
- The study uses rats, not humans, limiting direct applicability to pediatric care.
- Nr4a2 expression drops in the prefrontal cortex during acute stress responses.
- Higher GABA/glutamate ratios correlate with blunted brain activation and higher stress hormones.
- No clinical data, patient phenotypes, or therapeutic interventions are reported.
[Experimental animal model of multiple sclerosis--transverse investigation of MS pathogenesis for therapeutic intervention].
Oki S, Yamamura T
This study identifies NR4A2 as a marker for pathogenic T cells in multiple sclerosis and shows that blocking it improves symptoms in an animal model of the disease. The findings suggest NR4A2 blockade could be a therapeutic strategy for autoimmune conditions involving T cell activity, but they do not address the neurodevelopmental aspects of NR4A2 syndrome.
- NR4A2 is upregulated in T cells from multiple sclerosis patients and animal models.
- Pathogenic T cells exclusively express NR4A2 in this autoimmune context.
- Blocking NR4A2 with RNA interference reduces disease severity in mice.
- The study focuses on autoimmunity, not the neurodevelopmental phenotype of NR4A2 syndrome.
Shikonin, a constituent of Lithospermum erythrorhizon exhibits anti-allergic effects by suppressing orphan nuclear receptor Nr4a family gene expression as a new prototype of calcineurin inhibitors in mast cells.
Wang X, Hayashi S, Umezaki M, Yamamoto T, Kageyama-Yahara N, Kondo T, Kadowaki M
Shikonin suppresses allergic reactions in mast cells by inhibiting the calcineurin pathway, which subsequently reduces the expression of NR4A family genes including NR4A2. This mechanism mirrors how established immunosuppressants work, suggesting shikonin could potentially treat allergies by targeting this specific genetic pathway.
- Shikonin inhibits mast cell activation and allergic responses in cell models.
- The drug reduces expression of NR4A1, NR4A2, and NR4A3 genes.
- Shikonin blocks calcineurin activity similarly to known immunosuppressants like cyclosporin A.
- NR4A2 knockdown alone suppresses allergic inflammatory markers in mast cells.
miR-206 modulates lipopolysaccharide-mediated inflammatory cytokine production in human astrocytes.
Duan X, Zohaib A, Li Y, Zhu B, Ye J, Wan S, Xu Q, Song Y, Chen H, Cao S
This study shows that miR-206 increases inflammation in human astrocytes by directly suppressing NR4A2 protein levels. It identifies the molecular pathway where inflammatory signals trigger miR-206, which then reduces NR4A2 and activates other inflammatory pathways.
- miR-206 suppresses NR4A2 mRNA and protein in human astrocytes.
- Higher miR-206 levels increase inflammatory cytokine production.
- NR4A2 acts as a direct target of miR-206 regulation.
- The study uses cell culture models, not human patients or animals.
ReNCell VM conditioned medium enhances the induction of dental pulp stem cells into dopaminergic like cells.
Gnanasegaran N, Govindasamy V, Musa S, Abu Kasim NH
Pre-conditioning dental pulp stem cells with medium from neuron progenitor cells increases their expression of NR4A2 and other dopaminergic markers in a laboratory setting. This approach improves the cells' structural resemblance to dopaminergic neurons but remains a preclinical finding with no human application.
- Dental pulp stem cells gain dopaminergic features when pre-treated with neuron progenitor medium.
- NR4A2 expression increases significantly in these pre-conditioned stem cells.
- The study uses only cell cultures, with no animal or human data.
- This is basic laboratory research on cell differentiation techniques.
3,4-dihydroxyphenylethanol attenuates spatio-cognitive deficits in an Alzheimer's disease mouse model: modulation of the molecular signals in neuronal survival-apoptotic programs.
Arunsundar M, Shanmugarajan TS, Ravichandran V
This study shows that a compound found in olive oil improves memory and reduces brain cell death in mice with Alzheimer's-like symptoms. It works by restoring normal signaling pathways that control neuron survival, including the upregulation of Nurr1 (NR4A2). This research does not provide evidence for treating NR4A2-related syndromes in children.
- DOPET improves spatial memory in mice with Alzheimer's-like cognitive deficits.
- The compound restores survival signaling pathways disrupted by neurotoxicity.
- DOPET stabilizes apoptotic markers and preserves mitochondrial structure in neurons.
- Treatment increases expression of Nurr1 alongside other memory-related genes.
- Findings are limited to a mouse model of Alzheimer's disease.
Subplate in a rat model of preterm hypoxia-ischemia.
Okusa C, Oeschger F, Ginet V, Wang WZ, Hoerder-Suabedissen A, Matsuyama T, Truttmann AC, Molnár Z
In a rat model of preterm hypoxia-ischemia, subplate neurons did not show greater damage than other deep cortical layers or white matter, suggesting they are not uniquely vulnerable to injury in this model.
- Subplate cells were not more damaged than other deep cortical layers
- No specific vulnerability of subplate neurons was found
- Injury severity correlated with damage in layers V and VI
- White matter injury remained the primary focus in this model
Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice.
Montarolo F, Raffaele C, Perga S, Martire S, Finardi A, Furlan R, Hintermann S, Bertolotto A
Activating the Nurr1 protein reduces inflammation and nerve damage in mice with a multiple sclerosis-like condition. This finding suggests that boosting Nurr1 signaling might help control autoimmune inflammation in the central nervous system.
- Nurr1 normally suppresses pro-inflammatory signals in immune cells.
- A drug activating Nurr1 lowered disease severity in MS mice.
- The treatment reduced spinal cord inflammation and neurodegeneration.
- This is preclinical animal research, not human clinical data.
Activation of TGFβ1 signaling enhances early dopaminergic differentiation in unrestricted somatic stem cells.
Khanghahi AM, Zeynali B, Akhlaghpoor A, Tafreshi AP, Krieglstein K
Activating TGFβ1 signaling in stem cells increases the production of early dopaminergic neurons. This finding identifies a specific molecular pathway that promotes the development of dopamine-producing cells from stem sources.
- TGFβ1 treatment boosts Nurr-1 expression, an early marker for dopaminergic neurons.
- Blocking TGFβ signaling reduces neural and dopaminergic marker levels in stem cells.
- The study uses unrestricted somatic stem cells to demonstrate enhanced dopaminergic differentiation.
- Results suggest TGFβ signaling positively directs stem cells toward a dopaminergic fate.
Correlation between orphan nuclear receptor Nurr1 expression and amyloid deposition in 5XFAD mice, an animal model of Alzheimer's disease.
Moon M, Jeong I, Kim CH, Kim J, Lee PK, Mook-Jung I, Leblanc P, Kim KS
This study finds that Nurr1 protein levels decline in specific brain regions as amyloid plaques increase in a mouse model of Alzheimer's disease. The research suggests an association between altered Nurr1 expression and the progression of Alzheimer's pathology, but it does not address NR4A2-related syndromes or offer clinical insights for your child.
- The study uses a transgenic mouse model of Alzheimer's disease, not humans.
- Nurr1 protein co-localizes with amyloid-beta plaques in the subiculum and frontal cortex.
- Nurr1-expressing cells decrease significantly as mice age and plaque deposition increases.
- Findings link Nurr1 expression changes to Alzheimer's progression in this specific animal model.
C19MC microRNAs regulate the migration of human trophoblasts.
Xie L, Mouillet JF, Chu T, Parks WT, Sadovsky E, Knöfler M, Sadovsky Y
This study investigates how specific placental microRNAs control the movement of cells that implant into the uterus during pregnancy. It identifies NR4A2 as one of several genes targeted by these microRNAs to regulate cell migration, but it does not address NR4A2's role in brain development or neurological function.
- C19MC microRNAs reduce trophoblast cell migration without affecting survival or growth.
- miR-519d targets NR4A2 transcripts to indirectly influence invasive cell behavior.
- NR4A2 appears as an incidental target in placental biology, not neurodevelopment.
- The research focuses on pregnancy implantation mechanisms in human placental cells.
The NR4A receptors Nurr1 and Nur77 are increased in human placenta from women with gestational diabetes.
Lappas M
This study finds that NR4A2 (Nurr1) and related proteins are elevated in the placentas of women with gestational diabetes, where they appear to drive inflammatory responses. These findings describe a role for NR4A2 in placental physiology and maternal glucose metabolism rather than in the neurological development or symptoms associated with NR4A2 syndrome in children.
- NR4A2 levels are higher in placentas from mothers with gestational diabetes compared to healthy controls.
- Elevated NR4A2 increases the production of inflammatory signals in placental cells.
- The study focuses on maternal metabolic health, not child neurodevelopment or motor function.
- No clinical interventions or treatments for NR4A2 syndrome are discussed.
Longitudinal Analysis of DNA Methylation in CD34+ Hematopoietic Progenitors in Myelodysplastic Syndrome.
Wong YF, Micklem CN, Taguchi M, Itonaga H, Sawayama Y, Imanishi D, Nishikawa S, Miyazaki Y, Jakt LM
This study investigates DNA methylation patterns in blood stem cells from patients with myelodysplastic syndrome (MDS) to understand disease progression and treatment resistance. It identifies that the gene NR4A2 is suppressed by methylation in high-risk MDS, a mechanism linked to excessive stem cell proliferation in mouse models.
- Researchers analyzed DNA methylation in blood stem cells from MDS patients receiving AZA treatment.
- Limited demethylation after treatment suggests a resistant stem cell subset drives disease relapse.
- NR4A2 gene suppression via methylation correlates with high-risk MDS progression.
- Mouse models show NR4A2 haploinsufficiency causes excessive hematopoietic stem cell proliferation.
Angiotensin II triggers expression of the adrenal gland zona glomerulosa-specific 3β-hydroxysteroid dehydrogenase isoenzyme through de novo protein synthesis of the orphan nuclear receptors NGFIB and NURR1.
Ota T, Doi M, Yamazaki F, Yarimizu D, Okada K, Murai I, Hayashi H, Kunisue S, Nakagawa Y, Okamura H
This study explains how the hormone angiotensin II triggers the production of a specific enzyme in the adrenal gland by activating the NR4A2 (NURR1) protein. It identifies the molecular mechanism behind this process but does not investigate NR4A2 mutations or their effects on human health.
- Angiotensin II stimulates NURR1 production to regulate adrenal enzyme expression.
- The research uses human cell lines and mouse models for these findings.
- No clinical data, patient cohorts, or NR4A2 genetic variants are analyzed.
- The focus is on normal hormone signaling, not disease mechanisms.
The NR4A orphan nuclear receptors: mediators in metabolism and diseases.
Ranhotra HS
This review describes the general biological functions of NR4A2 and related proteins in metabolism, immunity, and disease progression. It does not provide specific clinical data or treatment insights for children with NR4A2-related syndromes.
- NR4A2 regulates diverse processes like metabolism, memory, and cardiac homeostasis.
- The paper reviews roles in cancer, inflammation, atherosclerosis, and obesity.
- No specific clinical evidence or treatment guidance for NR4A2 syndrome is included.
Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease.
L'Episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Serapide MF, Pluchino S, Marchetti B
Activating the Wnt/beta-catenin signaling pathway restores dopamine neuron production and improves movement in aged mice with Parkinson's-like damage. This study shows that age-related decline in this specific repair mechanism limits the brain's ability to regenerate dopamine neurons, but targeted activation can reverse these deficits.
- Aging restricts dopamine neuron regeneration by suppressing Wnt/beta-catenin signaling in mouse models.
- Glial cells from aged brains produce fewer Wnt factors, impairing stem cell repair potential.
- Activating beta-catenin with a specific drug restores dopamine neurons and motor function in aged mice.
- The study focuses on general Parkinson's mechanisms, not NR4A2-specific genetics or human trials.
Cell-based assays for Parkinson's disease using differentiated human LUHMES cells.
Zhang XM, Yin M, Zhang MH
This study uses a human cell line to screen for drugs that protect dopamine neurons from toxicity, but it does not test treatments on people or address NR4A2-related syndromes. The findings are strictly preclinical and do not provide clinical guidance for your child. No direct relevance to current management of NR4A2 variants is established.
- Uses human LUHMES cells as a model for Parkinson's disease research.
- Tests two specific inhibitors for neuroprotective effects in cell culture.
- Does not involve human patients or clinical trials.
- Focuses on general dopamine neuron toxicity, not NR4A2 biology.
- Results are preliminary and require animal or human validation.
MC1R and NR4A receptors in cellular stress and DNA repair: implications for UVR protection.
Yin K, Sturm RA, Smith AG
This review describes how NR4A2 helps skin cells repair DNA damage caused by ultraviolet radiation and suggests that drugs activating NR4A2 might prevent skin cancer. It does not provide information on NR4A2-related syndrome, neurological development, or treatments for children.
- NR4A2 aids DNA repair in melanocytes after UV exposure.
- The paper focuses entirely on skin biology and cancer prevention.
- No clinical data or relevance to pediatric neurodevelopmental disorders is presented.
Diverse roles for Wnt7a in ventral midbrain neurogenesis and dopaminergic axon morphogenesis.
Fernando CV, Kele J, Bye CR, Niclis JC, Alsanie W, Blakely BD, Stenman J, Turner BJ, Parish CL
Wnt7a regulates the production and survival of dopamine-producing neurons in the developing midbrain and guides their axons to correct targets. This process relies on the beta-catenin signaling pathway, which is distinct from the NR4A2/Nurr1 transcription factor mechanism.
- Wnt7a controls progenitor proliferation and survival in the ventral midbrain.
- It promotes axonal elongation and repels neurites out of the midbrain early on.
- Later, it prevents axons from crossing the midline and ensures correct trajectory.
- These effects are mediated by the beta-catenin/canonical Wnt pathway.
- The study uses mouse models and cell cultures, not human patients.
NR4A nuclear receptors are orphans but not lonesome.
Kurakula K, Koenis DS, van Tiel CM, de Vries CJ
This review explains how NR4A proteins, including Nurr1, function through interactions with other proteins rather than binding to specific chemical ligands. It details the known protein partners for Nur77 while noting that information on Nurr1 and NOR-1 remains limited.
- NR4A receptors lack known chemical ligands due to their unique protein structure.
- Protein-protein interactions regulate NR4A activity more than traditional ligand binding.
- Over 80 interacting proteins are identified for Nur77, but fewer for Nurr1.
- The paper reviews current knowledge on the interactomes of all three NR4A members.
Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription.
Meir T, Durlacher K, Pan Z, Amir G, Richards WG, Silver J, Naveh-Many T
This study shows that parathyroid hormone increases FGF23 levels by activating the protein Nurr1 in bone cells. The researchers demonstrate this mechanism using rat cell cultures and rat models of kidney disease, showing that reducing parathyroid hormone lowers Nurr1 and FGF23.
- PTH activates Nurr1 to increase FGF23 transcription in bone cells.
- Nurr1 binds directly to the FGF23 gene promoter region.
- Rat models of kidney disease show increased Nurr1 and FGF23.
- Reducing PTH lowers Nurr1 and FGF23 levels in rats.
Effect of 17β-estradiol on striatal dopaminergic transmission induced by permethrin in early childhood rats.
Nasuti C, Carloni M, Fedeli D, Di Stefano A, Marinelli L, Cerasa LS, Meda C, Maggi A, Gabbianelli R
This study finds that estrogen worsens dopamine loss in rat brains exposed to permethrin pesticide, suggesting a harmful interaction rather than protection. The results indicate that permethrin blocks estrogen receptors, preventing any potential neuroprotective benefits of estrogen treatment.
- Permethrin exposure reduces dopamine and Nurr1 gene expression in rat striatum.
- Adding estrogen to permethrin-exposed rats significantly worsens dopamine depletion.
- Permethrin acts as an antagonist, blocking estrogen receptors alpha and beta.
- Estrogen fails to protect against pesticide-induced dopaminergic damage in this model.
Efficient reprogramming of mouse fibroblasts to neuronal cells including dopaminergic neurons.
Oh SI, Park HS, Hwang I, Park HK, Choi KA, Jeong H, Kim SW, Hong S
Researchers successfully convert mouse skin cells into functional dopaminergic neurons using specific transcription factors and growth signals. This technique demonstrates a potential method for generating replacement cells for neurological disorders like Parkinson's disease.
- Mouse fibroblasts reprogram into dopaminergic neurons using Ascl1, Nurr1, SHH, and FGF8b.
- Reprogrammed cells express standard neuronal and dopaminergic markers in culture.
- Study uses mouse models, not human patients or NR4A2 variants.
- Focuses on cell generation methods rather than clinical treatment outcomes.
Characterization of claustral neurons by comparative gene expression profiling and dye-injection analyses.
Watakabe A, Ohsawa S, Ichinohe N, Rockland KS, Yamamori T
This study maps the expression of several genes, including NR4A2 (Nurr1), in the claustrum and surrounding cortex of rodents and macaques to understand brain connectivity. It finds that Nurr1 is present in specific claustral neurons but does not investigate its function, mutations, or relevance to human disease. The research provides no information on NR4A2-related syndromes or potential treatments.
- Researchers mapped gene expression in the claustrum and cortex of mice and macaques.
- NR4A2 (Nurr1) is expressed in claustral neurons that send projections to the cortex.
- The study focuses on anatomical connectivity, not gene function or disease mechanisms.
- No human patients, clinical data, or therapeutic insights are included.
Monocytes and CD4+ T cells contribution to the under-expression of NR4A2 and TNFAIP3 genes in patients with multiple sclerosis.
Navone ND, Perga S, Martire S, Berchialla P, Malucchi S, Bertolotto A
This study finds that the NR4A2 gene is under-expressed in monocytes of patients with multiple sclerosis, suggesting a role for these immune cells in the disease's inflammatory processes. The research does not involve children with NR4A2-related syndrome or offer direct clinical insights for this specific condition.
- NR4A2 expression is down-regulated in monocytes of multiple sclerosis patients.
- CD4+ T cells show only marginal changes in NR4A2 expression.
- The study focuses on immune mechanisms in adult MS, not pediatric neurodevelopment.
- No clinical treatments or genetic therapies for NR4A2 syndrome are discussed.
Repeated exposure to low doses of kainic acid activates nuclear factor kappa B (NF-κB) prior to seizure in transgenic NF-κB/EGFP reporter mice.
Miller JA, Kirkley KA, Padmanabhan R, Liang LP, Raol YH, Patel M, Bialecki RA, Tjalkens RB
This study found that low doses of kainic acid trigger early activation of the NF-κB stress pathway in hippocampal neurons before seizures occur, suggesting NF-κB could serve as a sensitive early warning signal for seizure risk. The same activation was seen in brain tissue cultures, supporting its use in testing drug safety.
- NF-κB activation occurs before seizures in response to low kainic acid doses
- Neuronal NF-κB rise happens without brain damage or inflammation
- Nurr1, a gene linked to NR4A2, increases alongside NF-κB
- This response is detectable in brain slice cultures
- NF-κB reporter mice may help screen drugs for seizure risk
Age-dependent dopaminergic dysfunction following fetal exposure to atrazine in SD rats.
Li Y, Sun Y, Yang J, Wu Y, Yu J, Li B
Exposure to the herbicide atrazine during fetal development in rats leads to lasting reductions in dopamine levels and key proteins involved in dopamine production and regulation in the brain, especially in areas critical for movement and reward. These changes persist into adulthood, suggesting early environmental toxin exposure can disrupt brain development with long-term consequences.
- Atrazine exposure in utero reduces dopamine levels in rat brains
- Key dopamine-related proteins remain low in adulthood
- Nurr1, TH, VMAT2, and DAT are all affected
- Changes persist into old age (1 year)
- Suggests early toxin exposure harms brain development
Novel markers identify nervous system components of the holothurian nervous system.
Díaz-Balzac CA, Vázquez-Figueroa LD, García-Arrarás JE
This study identifies three new markers that help detect nerve cells and fibers in sea cucumbers, which are closely related to vertebrates and can provide insights into how nervous systems evolved. The markers work across multiple sea cucumber species and reveal distinct parts of their nervous system.
- Three new markers identify nerve cells in sea cucumbers
- Markers work across multiple sea cucumber species
- Helps map and study the sea cucumber nervous system
- Provides tools to study nervous system evolution
Dysregulation of dopaminergic regulatory mechanisms in the mesolimbic pathway induced by morphine and morphine withdrawal.
García-Pérez D, López-Bellido R, Rodríguez RE, Laorden ML, Núñez C, Milanés MV
Morphine exposure and withdrawal alter the nuclear localization of Nurr1 in dopamine neurons within the brain's reward circuitry. These changes occur without affecting the total number of dopamine or Nurr1-positive cells.
- Morphine induces Nurr1 expression in the ventral tegmental area.
- Nurr1 shifts to the nucleus during morphine dependence.
- Pitx3 localizes to the nucleus after single morphine doses and withdrawal.
- Dopamine neuron counts remain stable despite these molecular changes.
Engineering of midbrain organoids containing long-lived dopaminergic neurons.
Tieng V, Stoppini L, Villy S, Fathi M, Dubois-Dauphin M, Krause KH
Researchers developed a rapid method to grow midbrain-like tissue from stem cells that produces dopaminergic neurons. This engineered tissue serves as a tool for drug screening and studying Parkinson's disease mechanisms in the lab.
- Protocol generates dopaminergic neurons in three weeks using size-calibrated neurospheres.
- Engineered tissue contains active neurons and glial cells with midbrain characteristics.
- Three-week-old neurospheres yield optimal dopaminergic neurons with A9 morphology.
- Four-week cultures produce excessive glial cells at the expense of neurons.
- Compound E is more effective than DAPT for generating these specific neurons.
The lifelong maintenance of mesencephalic dopaminergic neurons by Nurr1 and engrailed.
Alavian KN, Jeddi S, Naghipour SI, Nabili P, Licznerski P, Tierney TS
This review explains how the transcription factors Nurr1 and Engrailed work together to maintain midbrain dopaminergic neurons throughout life. It details their roles in neuron development, neurotransmitter identity, and protection against degeneration seen in Parkinson's disease.
- Nurr1 and Engrailed are essential for the long-term survival of midbrain dopaminergic neurons.
- These factors regulate neuron differentiation, maturation, and acquisition of neurotransmitter identity.
- The paper reviews their relationship to neuronal vulnerability and death in Parkinson's disease.